A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

FDA Analysis Shows J&J’s COVID-19 Vaccine Is Effective


The United States Food and Drug Administration (FDA) released its own analysis of Johnson & Johnson’s (J&J) one-shot, easily stored COVID-19 vaccine, finding that the immunization protects against severe COVID-19 illness and death, and may limit spread of the novel coronavirus. Released on February 24, the report cites a 72% rate of effectiveness overall and an 86% rate of effectiveness against severe COVID-19 illness. The FDA is expected to issue an Emergency Use Authorization for the J&J vaccine by Saturday, February 27. Click here to read more.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy